Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort. - Rha, Sun Young; Castanon, Eduardo; Gill, Sanjeev; Senellart, Helene; Lopez, Juanita; Márquez‐Rodas, Iván; Victoria, Iván; Kim, Tae Min; Lwin, Zarnie; Burger, Michael C.; Simonelli, Matteo; Cassier, Philippe A.; et al. (Cancer (0008543X), 2025)